• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.13% Nasdaq Down0.93%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    0.95 Down 0.01(1.04%) Jan 28, 3:56PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 872   1,846   15,289   323  
    Cost of Revenue -   -   -   -  
    Gross Profit 872   1,846   15,289   323  
    Operating Expenses
    Research Development8,485  9,300  11,767  11,889  
    Selling General and Administrative5,085  4,845  5,555  4,499  
    Non Recurring1,401  5,166  3,859  4  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (14,099) (17,465) (5,892) (16,069)
    Income from Continuing Operations
    Total Other Income/Expenses Net102  8  23  20  
    Earnings Before Interest And Taxes(13,997)(17,457)(5,869)(16,049)
    Interest Expense439  502  581  676  
    Income Before Tax(14,436)(17,959)(6,450)(16,725)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(14,436)(17,959)(6,450)(16,725)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (14,436) (17,959) (6,450) (16,725)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (14,436) (17,959) (6,450) (16,725)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.